156 related articles for article (PubMed ID: 22926332)
41. Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs.
Yarbrough WM; Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Escobar GP; Joffs C; Lucas DG; Crawford FA; Spinale FG
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):602-10. PubMed ID: 12658202
[TBL] [Abstract][Full Text] [Related]
42. Trapped platelets activated in ischemia initiate ventricular fibrillation.
Dhanjal TS; Medina RA; Leem J; Clark JE; Southworth R; Curtis MJ
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):995-1001. PubMed ID: 23995251
[TBL] [Abstract][Full Text] [Related]
43. Myocardial Upregulation of Cathepsin D by Ischemic Heart Disease Promotes Autophagic Flux and Protects Against Cardiac Remodeling and Heart Failure.
Wu P; Yuan X; Li F; Zhang J; Zhu W; Wei M; Li J; Wang X
Circ Heart Fail; 2017 Jul; 10(7):. PubMed ID: 28694354
[TBL] [Abstract][Full Text] [Related]
44. Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype.
Rogers RG; Otis JS
Cardiovasc Drugs Ther; 2017 Feb; 31(1):29-38. PubMed ID: 28064408
[TBL] [Abstract][Full Text] [Related]
45. Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats.
Delucchi F; Berni R; Frati C; Cavalli S; Graiani G; Sala R; Chaponnier C; Gabbiani G; Calani L; Del Rio D; Bocchi L; Lagrasta C; Quaini F; Stilli D
PLoS One; 2012; 7(6):e39836. PubMed ID: 22768138
[TBL] [Abstract][Full Text] [Related]
46. Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction.
Chen YR; Yi FF; Li XY; Wang CY; Chen L; Yang XC; Su PX; Cai J
Cardiovasc Drugs Ther; 2008 Dec; 22(6):479-85. PubMed ID: 18853243
[TBL] [Abstract][Full Text] [Related]
47. Therapeutic potential of resveratrol in heart failure.
Sung MM; Dyck JR
Ann N Y Acad Sci; 2015 Aug; 1348(1):32-45. PubMed ID: 26205211
[TBL] [Abstract][Full Text] [Related]
48. Resveratrol preserves myocardial function and perfusion in remote nonischemic myocardium in a swine model of metabolic syndrome.
Robich MP; Chu LM; Burgess TA; Feng J; Han Y; Nezafat R; Leber MP; Laham RJ; Manning WJ; Sellke FW
J Am Coll Surg; 2012 Nov; 215(5):681-9. PubMed ID: 22867714
[TBL] [Abstract][Full Text] [Related]
49. Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy.
Das SK; Wang W; Zhabyeyev P; Basu R; McLean B; Fan D; Parajuli N; DesAulniers J; Patel VB; Hajjar RJ; Dyck JR; Kassiri Z; Oudit GY
Sci Rep; 2015 Dec; 5():18132. PubMed ID: 26638758
[TBL] [Abstract][Full Text] [Related]
50. Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model.
Akodad M; Fauconnier J; Sicard P; Huet F; Blandel F; Bourret A; de Santa Barbara P; Aguilhon S; LeGall M; Hugon G; Lacampagne A; Roubille F
Int J Cardiol; 2017 Aug; 240():347-353. PubMed ID: 28395979
[TBL] [Abstract][Full Text] [Related]
51. Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia.
Robich MP; Osipov RM; Chu LM; Han Y; Feng J; Nezafat R; Clements RT; Manning WJ; Sellke FW
Eur J Pharmacol; 2011 Aug; 664(1-3):45-53. PubMed ID: 21575630
[TBL] [Abstract][Full Text] [Related]
52. Lidocaine Enhances Contractile Function of Ischemic Myocardial Regions in Mouse Model of Sustained Myocardial Ischemia.
Müller-Edenborn B; Kania G; Osto E; Jakob P; Krasniqi N; Beck-Schimmer B; Blyszczuk P; Eriksson U
PLoS One; 2016; 11(5):e0154699. PubMed ID: 27140425
[TBL] [Abstract][Full Text] [Related]
53. Investigating the effects of resveratrol on chronically ischemic myocardium in a swine model of metabolic syndrome: a proteomics analysis.
Sabe AA; Sadek AA; Elmadhun NY; Dalal RS; Robich MP; Bianchi C; Sellke FW
J Med Food; 2015 Jan; 18(1):60-6. PubMed ID: 25089828
[TBL] [Abstract][Full Text] [Related]
54. Restoration of altered microRNA expression in the ischemic heart with resveratrol.
Mukhopadhyay P; Mukherjee S; Ahsan K; Bagchi A; Pacher P; Das DK
PLoS One; 2010 Dec; 5(12):e15705. PubMed ID: 21203465
[TBL] [Abstract][Full Text] [Related]
55. A Retinoic Acid Receptor
Tang XH; Gambardella J; Jankauskas S; Wang X; Santulli G; Gudas LJ; Levi R
J Pharmacol Exp Ther; 2021 Nov; 379(2):182-190. PubMed ID: 34389654
[TBL] [Abstract][Full Text] [Related]
56. Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions.
Nakaoka H; Nakagawa-Toyama Y; Nishida M; Okada T; Kawase R; Yamashita T; Yuasa-Kawase M; Nakatani K; Masuda D; Ohama T; Sonobe T; Shirai M; Komuro I; Yamashita S
PLoS One; 2013; 8(8):e70755. PubMed ID: 23950999
[TBL] [Abstract][Full Text] [Related]
57. Involvement of HIF1α/Reg protein in the regulation of HMGB3 in myocardial infarction.
Manhas A; Tripathi D; Jagavelu K
Vascul Pharmacol; 2023 Oct; 152():107197. PubMed ID: 37467910
[TBL] [Abstract][Full Text] [Related]
58. Ex vivo and in vivo approaches to study mechanisms of cardioprotection targeting ischemia/reperfusion (i/r) injury: useful techniques for cardiovascular drug discovery.
Vidavalur R; Swarnakar S; Thirunavukkarasu M; Samuel SM; Maulik N
Curr Drug Discov Technol; 2008 Dec; 5(4):269-78. PubMed ID: 19075607
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA signatures of resveratrol in the ischemic heart.
Mukhopadhyay P; Pacher P; Das DK
Ann N Y Acad Sci; 2011 Jan; 1215():109-16. PubMed ID: 21261648
[TBL] [Abstract][Full Text] [Related]
60. Coronary artery disease progression is associated with increased resistance of hearts and myocytes to cardiac insults.
Chase A; Jackson CL; Angelini GL; Suleiman MS
Crit Care Med; 2007 Oct; 35(10):2344-51. PubMed ID: 17944024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
